News

Radon is the second-leading cause of lung cancer, but now a researcher at NOSM University in Sudbury is investigating if ...
A pair of recent studies from the laboratory of Bin Zhang, MD, Ph.D., the Johanna Dobe Professor of Cancer Immunology, have ...
A team from the Montreal Clinical Research Institute has identified a protein that could play a role in the spread of breast ...
The company, founded in 2019 by quantum physics researcher Maximilien Levesque and Emmanuelle Martiano, a former consultant ...
There are two main types of lung cancer ... approach that tailors cancer care and lifestyle recommendations to each patients’ biopsychosocial-spiritual circumstances. He partners with patients ...
Broad Institute researchers have developed a way to edit the genetic sequences at the root of Huntington's disease and ...
"While the overall survival rates for patients with non-small cell lung cancer have significantly improved in recent years, lung cancer continues to be the leading cause of cancer death worldwide ...
Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...
Mice genetically engineered to lack the ability to make the amino acid cysteine, and fed a cysteine-free diet, lost 30 percent of their body weight in just one week, a new study shows.
New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.
Background Insomnia symptoms are prevalent in older adults and linked to cardiovascular disease (CVD), but the role of ...